Endometrial cancer: open trials in Switzerland

• NCT06760819

  A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  Trial Treatment · Phase 2 · Bayer

  Inselspital Bern - Universitätsklinik für Medizinische Onkologie, Bern · Hopitaux Universitaires de Geneve - Oncology Department, Geneva · UniversitätsSpital Zürich (USZ) - Klinik für Medizinische Onkologie und Hämatologie, Zurich

  Registry updated 2026-11-04

• NCT06989112

  DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  Trial Treatment · Phase 3 · AstraZeneca

  Frauenfeld · Liestal · Sankt Gallen · Zurich

  Registry updated 2026-10-13

• NCT05489211

  Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  Trial Treatment · Phase 2 · AstraZeneca

  Basel · Bellinzona · Sankt Gallen

  Registry updated 2026-09-23

• NCT06689956

  Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study

  Research · Mayo Clinic

  Ospedale Regionale di Lugano - Civico, Lugano

  Registry updated 2026-02-19

All Endometrial cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error